Your browser doesn't support javascript.
loading
IncobotulinumtoxinA (Xeomin): background, mechanism of action, and manufacturing.
Lorenc, Z Paul; Kenkel, Jeffrey M; Fagien, Steven; Hirmand, Haideh; Nestor, Mark S; Sclafani, Anthony P; Sykes, Jonathan M; Waldorf, Heidi A.
  • Lorenc ZP; Private practice in New York, New York, USA. lorenc@lorenc.com
Aesthet Surg J ; 33(1 Suppl): 18S-22S, 2013 Mar.
Article en En | MEDLINE | ID: mdl-23515195
ABSTRACT
IncobotulinumtoxinA is the third botulinum neurotoxin type A (BoNTA) to be approved for aesthetic use in the United States. This article introduces the new product with an overview of clinical applications and a discussion of the neurotoxin's molecular structure. The role and clinical relevance of complexing proteins in BoNTA products are discussed. Finally, incobotulinumtoxinA's mechanism of action is described.
Asunto(s)

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Rejuvenecimiento / Neurotransmisores / Toxinas Botulínicas Tipo A / Cara Límite: Humans Idioma: En Año: 2013 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Rejuvenecimiento / Neurotransmisores / Toxinas Botulínicas Tipo A / Cara Límite: Humans Idioma: En Año: 2013 Tipo del documento: Article